EUVIMED · CrossrefJournal
The Breast
ISSN 0960-9776 · Elsevier BV
Latest articles
Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE)
8th International consensus guidelines for the management of advanced breast cancer (ABC8 guidelines)
Performance of large language models in ambiguous treatment scenarios of early breast cancer
Knowledge gaps and future perspectives for the definition, diagnostics and treatment of isolated locoregional recurrent breast cancer
Longitudinal trajectories of menopausal symptoms in women receiving endocrine therapy for breast cancer compared with natural menopause
Impact of old age, comorbidity, and polypharmacy on adjuvant endocrine therapy for patients with early-stage breast cancer
Can CanAssist Breast guide the duration of extended endocrine therapy?
Use of prepectoral polyurethane coated implants in the setting of radiotherapy: the OPBC-09 PRExRT retrospective cohort study
Incidence and mortality of breast cancer among adolescent and young adult women worldwide in 2022 and projections for 2040: Implications for surgery
Impact of multidisciplinary tumor meetings on clinical outcomes, treatment concordance, and guideline adherence in breast cancer: a systematic review with emphasis on older patients
Editorial Board
Can surgical axillary staging be safely omitted in early-stage invasive lobular carcinoma? Results from a large multicenter retrospective study
Reirradiation After Repeat Breast Conserving Treatment: Contemporary Evidence, Technical Approaches, and Expert Recommendations
Clinical and AI-derived Digital Pathology Features of Invasive Lobular and Ductal Carcinoma for Predicting 5-Year Recurrence or Metastasis
Regional nodal irradiation might not improve locoregional recurrence-free survival in ypN0 breast cancer patients undergoing neoadjuvant chemotherapy
Factors associated with interval breast cancer in screened populations: a systematic review
Deep learning-based assessment of residual breast cancer after neoadjuvant treatment predicts outcomes
End-of-life care values and treatment preferences among Japanese breast cancer patients and families: A dyadic cross-sectional study
Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial
EUSOMA recommendations without EUSOMA certification: a credibility gap
Letter to the Editor on: A. G. Nerlich, J. C. Dewaal, A. Perciaccante, S. Di Cosimo, L. Cortesi, J. Wimmer, S. T. Donnell, R, Bianucci: Did Michelangelo paint a young adult woman with breast cancer in “The Flood” (Sistine Chapel, Rome)? Breast 2024, 78, 103823
Identifying pre-treatment risk factors for cancer-related cognitive decline in patients with breast cancer
24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial
WITHDRAWN: From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2– breast cancer
HER2-directed therapy is associated with an increased rate of cardiologic emergency department visits in real-world breast cancer patients
Evaluation of a novel communication workshop for healthcare professionals working with metastatic breast cancer patients
Baseline clinical and laboratory profiles at breast cancer diagnosis in Tanzania: differences by HIV status
Overall survival outcomes in occult primary breast cancer
Corrigendum to “From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2– breast cancer” [The Breast 88 (2026) 104791]
Volumes
2027 · 12026 · 2612025 · 7512024 · 1832023 · 6622022 · 1752021 · 5152020 · 2162019 · 7302018 · 2912017 · 7522016 · 1872015 · 7352014 · 2542013 · 3872012 · 2532011 · 5742010 · 1252009 · 3702008 · 1422007 · 3522006 · 1662005 · 2822004 · 1182003 · 2622002 · 1262001 · 1612000 · 811999 · 891998 · 1001997 · 3311996 · 1341995 · 2141994 · 801993 · 1791992 · 154
EUVIMED